Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Up 154.7% in March

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,700,000 shares, an increase of 154.7% from the February 28th total of 1,060,000 shares. Based on an average trading volume of 14,650,000 shares, the short-interest ratio is presently 0.2 days. Currently, 25.8% of the company’s shares are short sold.

Sharps Technology Price Performance

Shares of STSS opened at $0.12 on Friday. The stock has a market capitalization of $637,768.00, a price-to-earnings ratio of -0.01 and a beta of 1.47. The firm has a 50-day moving average price of $0.52. Sharps Technology has a 12-month low of $0.12 and a 12-month high of $18.15.

Sharps Technology (NASDAQ:STSS) last announced its quarterly earnings results on Thursday, March 27th. The company reported ($2.87) EPS for the quarter.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Essential Planning LLC. boosted its holdings in Sharps Technology by 22.7% during the 4th quarter. Essential Planning LLC. now owns 199,854 shares of the company’s stock valued at $412,000 after acquiring an additional 37,029 shares during the period. Garden State Investment Advisory Services LLC acquired a new stake in Sharps Technology in the third quarter valued at $26,000. Finally, Anson Funds Management LP purchased a new stake in Sharps Technology during the 4th quarter worth about $76,000. 17.17% of the stock is currently owned by institutional investors and hedge funds.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.